| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |